Amgen Inc.
AMGN
$336.81
$0.520.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.38% | 7.47% | 12.10% | 9.08% | 10.61% |
| Total Other Revenue | 44.93% | 34.86% | 19.32% | 17.58% | -16.11% |
| Total Revenue | 5.76% | 8.58% | 12.40% | 9.43% | 9.43% |
| Cost of Revenue | -4.15% | -1.33% | 3.59% | 3.73% | 3.91% |
| Gross Profit | 10.41% | 12.80% | 16.38% | 11.96% | 12.23% |
| SG&A Expenses | -5.04% | 3.94% | 5.85% | -5.27% | -6.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -476.67% | -52.33% | -200.00% | 153.54% | -18.92% |
| Total Operating Expenses | -1.77% | 5.64% | 8.59% | 8.70% | 1.98% |
| Operating Income | 24.43% | 15.92% | 20.53% | 10.97% | 33.62% |
| Income Before Tax | 5.63% | 93.61% | 26.44% | 97.48% | 3,001.47% |
| Income Tax Expenses | 9.05% | 16.77% | 160.15% | 183.33% | 440.00% |
| Earnings from Continuing Operations | 5.14% | 112.60% | 13.64% | 91.96% | 1,630.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.14% | 112.60% | 13.64% | 91.96% | 1,630.97% |
| EBIT | 24.43% | 15.92% | 20.53% | 10.97% | 33.62% |
| EBITDA | 8.07% | 3.50% | 11.38% | 5.79% | 18.31% |
| EPS Basic | 4.75% | 111.81% | 13.43% | 91.60% | 1,625.43% |
| Normalized Basic EPS | 78.28% | 30.40% | 32.94% | 27.68% | 16.72% |
| EPS Diluted | 4.38% | 112.06% | 13.60% | 92.03% | 1,618.03% |
| Normalized Diluted EPS | 77.96% | 30.64% | 33.18% | 27.91% | 16.07% |
| Average Basic Shares Outstanding | 0.37% | 0.37% | 0.19% | 0.19% | 0.37% |
| Average Diluted Shares Outstanding | 0.55% | 0.18% | 0.00% | 0.00% | 0.93% |
| Dividend Per Share | 5.88% | 5.78% | 5.78% | 5.78% | 5.78% |
| Payout Ratio | 0.01% | -0.50% | -0.07% | -0.45% | 1.07% |